(NYSE: RMD) Resmed's forecast annual revenue growth rate of 4.97% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.3%.
Resmed's revenue in 2024 is $4,504,077,000.On average, 7 Wall Street analysts forecast RMD's revenue for 2024 to be $683,671,504,846, with the lowest RMD revenue forecast at $679,683,042,559, and the highest RMD revenue forecast at $690,750,010,492. On average, 7 Wall Street analysts forecast RMD's revenue for 2025 to be $728,712,475,774, with the lowest RMD revenue forecast at $721,323,906,752, and the highest RMD revenue forecast at $735,002,437,892.
In 2026, RMD is forecast to generate $778,145,815,075 in revenue, with the lowest revenue forecast at $764,832,799,822 and the highest revenue forecast at $786,794,788,779.